Cargando…

Antikörperkombination zur COVID-19-Therapie

Detalles Bibliográficos
Autor principal: Facharztmagazine, Redaktion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663187/
http://dx.doi.org/10.1007/s11298-022-3049-8
_version_ 1784830817267089408
author Facharztmagazine, Redaktion
author_facet Facharztmagazine, Redaktion
author_sort Facharztmagazine, Redaktion
collection PubMed
description
format Online
Article
Text
id pubmed-9663187
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-96631872022-11-14 Antikörperkombination zur COVID-19-Therapie Facharztmagazine, Redaktion CME (Berl) Therapie Aktuell Springer Medizin 2022-11-15 2022 /pmc/articles/PMC9663187/ http://dx.doi.org/10.1007/s11298-022-3049-8 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Therapie Aktuell
Facharztmagazine, Redaktion
Antikörperkombination zur COVID-19-Therapie
title Antikörperkombination zur COVID-19-Therapie
title_full Antikörperkombination zur COVID-19-Therapie
title_fullStr Antikörperkombination zur COVID-19-Therapie
title_full_unstemmed Antikörperkombination zur COVID-19-Therapie
title_short Antikörperkombination zur COVID-19-Therapie
title_sort antikörperkombination zur covid-19-therapie
topic Therapie Aktuell
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663187/
http://dx.doi.org/10.1007/s11298-022-3049-8
work_keys_str_mv AT facharztmagazineredaktion antikorperkombinationzurcovid19therapie